AN2 Therapeutics annual total assets
2021
2022
2023
2024
2025
AN2 Therapeutics Total Assets Growth & History (ANTX)
AN2 Therapeutics's total assets was $62.0M for fiscal 2025.
View full AN2 Therapeutics company overviewAN2 Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $62.0M | −$30.1M | −32.73% |
| 2024 | 2024-12-31 | $92.1M | −$46.7M | −33.63% |
| 2023 | 2023-12-31 | $138.7M | $36.2M | +35.28% |
| 2022 | 2022-12-31 | $102.6M | $37.2M | +57.02% |
| 2021 | 2021-12-31 | $65.3M | — | — |
AN2 Therapeutics quarterly total assets
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $81.7M | $5.9M | +7.72% |
| Q1 2026 | 2026-03-31 | $87.5M | $6.1M | +7.56% |
| Q4 2025 | 2025-12-31 | $62.0M | −$30.1M | −32.73% |
| Q3 2025 | 2025-09-30 | $67.2M | −$30.5M | −31.17% |
| Q2 2025 | 2025-06-30 | $75.8M | −$32.7M | −30.10% |
| Q1 2025 | 2025-03-31 | $81.3M | −$39.9M | −32.92% |
| Q4 2024 | 2024-12-31 | $92.1M | −$46.7M | −33.63% |
| Q3 2024 | 2024-09-30 | $97.7M | −$56.1M | −36.49% |
| Q2 2024 | 2024-06-30 | $108.5M | $9.6M | +9.66% |
| Q1 2024 | 2024-03-31 | $121.3M | $30.2M | +33.13% |
| Q4 2023 | 2023-12-31 | $138.7M | $36.2M | +35.28% |
| Q3 2023 | 2023-09-30 | $153.8M | $43.8M | +39.82% |
| Q2 2023 | 2023-06-30 | $98.9M | −$21.1M | −17.57% |
| Q1 2023 | 2023-03-31 | $91.1M | −$29.4M | −24.41% |
| Q4 2022 | 2022-12-31 | $102.6M | $37.2M | +57.02% |
| Q3 2022 | 2022-09-30 | $110.0M | — | — |
| Q2 2022 | 2022-06-30 | $120.0M | — | — |
| Q1 2022 | 2022-03-31 | $120.5M | — | — |
| Q4 2021 | 2021-12-31 | $65.3M | — | — |
AN2 Therapeutics total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, AN2 Therapeutics's total assets decreased from $65.3M to $62.0M, a change of −$3.4M. The latest reported quarter, Q2 2026, shows $81.7M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AN2 Therapeutics source filings ↗